Skip to main content

Syndicate contentbreast cancer

Breastfeeding reduces risk of breast cancer in women with a family history of the disease

CHAPEL HILL -- According to a new study, women with a family history of breast cancer were 59 percent less likely to develop breast cancer themselves if they breastfed their children.

Breastfeeding associated with reduced risk of breast cancer among women with family history

Women with a family history of breast cancer appear to have a lower risk of developing the disease before menopause if they have ever breastfed a child, according to a report in the August 10/24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

New discovery brings hope to treatment of lymphatic diseases

LEXINGTON, Ky. (Aug. 10, 2009) − Researchers in the laboratory of Dr. Jayakrishna Ambati at the University of Kentucky have discovered the first naturally occurring molecule that selectively blocks lymphatic vessel growth. In an article in the Aug.

Stanford scientists find common trigger in cancer and normal stem cell reproduction

STANFORD, Calif. -- Researchers at Stanford University School of Medicine have discovered, for the first time, a common molecular pathway that is used by both normal stem cells and cancer stem cells when they reproduce themselves.

Women often opt to surgically remove their breasts, ovaries to reduce cancer risk

PHILADELPHIA -- Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Protein complex key in avoiding DNA repair mistakes, cancer

ANN ARBOR, Mich. -- As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows.

Nerve-block anesthesia can improve surgical recovery, even outcomes

NEW YORK (August 4, 2009) -- When planning for surgery, patients too often don't consider the kind of anesthesia they will receive. In fact, the choice of anesthesia can improve recovery, even outcomes.

The way you eat may affect your risk for breast cancer

PHILADELPHIA -- How you eat may be just as important as how much you eat, if mice studies are any clue.

Mathematical modeling predicts response to Herceptin

PHILADELPHIA -- Cancer researchers are turning to mathematical models to help answer important clinical questions, and a new paper in Cancer Research, a journal of the American Association for Cancer Research, illustrates how the technique may answer questions about Herceptin resistance.

Could therapeutic vaccines treat hard to beat breast cancers?

A comprehensive analysis of nearly 1,600 tumor samples has found that CT-X genes are expressed in nearly half the breast cancers that lack the estrogen receptor (ER). CT-X gene products are the targets of therapeutic cancer vaccines already in phase III clinical trials for lung cancer and melanoma.

Cancer's distinctive pattern of gene expression could aid early screening and prevention

AUGUSTA, Ga. -- Distinctive patterns of genes turned off -- or left on -- in healthy versus cancerous cells could enable early screening for many common cancers and maybe help avoid them, Medical College of Georgia scientists say.

Surgery remans an option for advanced lung cancer

MAYWOOD, Il. -- In recent years, oncologists have debated whether patients with a certain type of advanced lung cancer would benefit from surgery.

Life after chemotherapy: Daily tasks, quality of life may be affected, MU researcher finds

COLUMBIA, Mo. - Each day, thousands of people undergo chemotherapy treatments for different types of cancer, and it is widely known that patients are negatively affected during the treatments; previous research has shown decreases in cognitive functioning among cancer survivors following treatment.

Breast cancer drug shows promise against serious infections

An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes